A search on PubMed returns many papers on rodents and cell models, and reviews on PubMed Central describe it as a possible therapy rather than a proven one
C14H22N4O9) is a synthetic tetrapeptide supplied for qualified laboratory research use
Reactions of interest included dyspnoea, asthma, chronic obstructive pulmonary disease (COPD), obstructive airways disease (OAD), wheezing, cough, bronchospasm, asthma-chronic obstructive pulmonary disease, alveolar lung disease, emphysema, combined pulmonary fibrosis and emphysema, idiopathic pulmonary fibrosis (IPF), irregular breathing, respiration abnormal, productive cough or respiratory disorder
Downregulation of MFN2 reduces mitochondrial-ER contact, impairing calcium signaling and lipid exchange, thereby exacerbating ERS and ATP deficiency [204]